Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
8.05
-0.07 (-0.86%)
At close: Oct 8, 2025, 4:00 PM EDT
8.05
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:10 PM EDT

Evolent Health Statistics

Total Valuation

Evolent Health has a market cap or net worth of $933.57 million. The enterprise value is $1.65 billion.

Market Cap933.57M
Enterprise Value 1.65B

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, after market close.

Earnings Date Nov 6, 2025
Ex-Dividend Date n/a

Share Statistics

Evolent Health has 115.97 million shares outstanding. The number of shares has increased by 1.40% in one year.

Current Share Class 115.97M
Shares Outstanding 115.97M
Shares Change (YoY) +1.40%
Shares Change (QoQ) +0.49%
Owned by Insiders (%) 1.68%
Owned by Institutions (%) 91.29%
Float 91.32M

Valuation Ratios

PE Ratio n/a
Forward PE 15.71
PS Ratio 0.43
Forward PS 0.44
PB Ratio 1.05
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.75
EV / EBITDA 22.85
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.01, with a Debt / Equity ratio of 0.76.

Current Ratio 1.01
Quick Ratio 0.91
Debt / Equity 0.76
Debt / EBITDA 10.95
Debt / FCF n/a
Interest Coverage -0.24

Financial Efficiency

Return on equity (ROE) is -11.04% and return on invested capital (ROIC) is -0.27%.

Return on Equity (ROE) -11.04%
Return on Assets (ROA) -0.21%
Return on Invested Capital (ROIC) -0.27%
Return on Capital Employed (ROCE) -0.44%
Revenue Per Employee $487,982
Profits Per Employee -$41,152
Employee Count4,500
Asset Turnover 0.89
Inventory Turnover n/a

Taxes

Income Tax -1.10M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -68.89% in the last 52 weeks. The beta is 0.66, so Evolent Health's price volatility has been lower than the market average.

Beta (5Y) 0.66
52-Week Price Change -68.89%
50-Day Moving Average 9.09
200-Day Moving Average 9.68
Relative Strength Index (RSI) 40.17
Average Volume (20 Days) 3,218,697

Short Selling Information

The latest short interest is 23.10 million, so 19.92% of the outstanding shares have been sold short.

Short Interest 23.10M
Short Previous Month 20.29M
Short % of Shares Out 19.92%
Short % of Float 25.29%
Short Ratio (days to cover) 7.22

Income Statement

In the last 12 months, Evolent Health had revenue of $2.20 billion and -$185.19 million in losses. Loss per share was -$1.61.

Revenue2.20B
Gross Profit 359.26M
Operating Income -8.35M
Pretax Income -131.55M
Net Income -185.19M
EBITDA 72.25M
EBIT -8.35M
Loss Per Share -$1.61
Full Income Statement

Balance Sheet

The company has $151.00 million in cash and $853.19 million in debt, giving a net cash position of -$702.20 million or -$6.05 per share.

Cash & Cash Equivalents 151.00M
Total Debt 853.19M
Net Cash -702.20M
Net Cash Per Share -$6.05
Equity (Book Value) 1.12B
Book Value Per Share 7.73
Working Capital 4.74M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$33.33 million and capital expenditures -$88.13 million, giving a free cash flow of -$121.46 million.

Operating Cash Flow -33.33M
Capital Expenditures -88.13M
Free Cash Flow -121.46M
FCF Per Share -$1.05
Full Cash Flow Statement

Margins

Gross margin is 16.36%, with operating and profit margins of -0.38% and -5.94%.

Gross Margin 16.36%
Operating Margin -0.38%
Pretax Margin -5.99%
Profit Margin -5.94%
EBITDA Margin 3.29%
EBIT Margin -0.38%
FCF Margin n/a

Dividends & Yields

Evolent Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.40%
Shareholder Yield -1.40%
Earnings Yield -19.52%
FCF Yield -12.80%
Dividend Details

Analyst Forecast

The average price target for Evolent Health is $17.07, which is 112.05% higher than the current price. The consensus rating is "Strong Buy".

Price Target $17.07
Price Target Difference 112.05%
Analyst Consensus Strong Buy
Analyst Count 15
Revenue Growth Forecast (5Y) 7.60%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Evolent Health has an Altman Z-Score of 1.21 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.21
Piotroski F-Score 1